Join us you will be able to get the following rights
Get fresh academic and clinical information
Sign up for exclusive endoscopy contests and training courses
Use online training software
Watch the LIVE of academic conferences and surgery
LCI中的薰衣草紫色可实现胃肠化生的无创检测
LCI中的薰衣草紫色可实现胃肠化生的无创检测
LCI中的薰衣草紫色可实现胃肠化生的无创检测
Lavender Color in Linked Color Imaging Enables Noninvasive Detection of Gastric Intestinal Metaplasia
S Ono, M Kato, M Tsuda, S Miyamoto, S Abiko… - Digestion, 2018
LCI是一种新的用于常规内镜检查中检测GIM的诊断工具。
Conclusions: LCI could be a new diagnostic tool for detecting GIM during routine endoscopy.
01
背景和研究目的
最近,有一些图像增强技术可以提高胃肠化生(GIM)检测的报道。我们旨在确定LCI对于GIM检测的有效性。
Background and Aims: Recently, there have been some reports that image-enhanced endoscopy may improve detection of gastric intestinal metaplasia (GIM). Our aim was to determine the usefulness of linked color imaging (LCI) for detection of GIM.
02
方法
在前瞻性招募的患者中,先用LCI再用白光观察整个胃窦。当白光检测到白色平坦隆起(WFE)和LCI模式下薰衣草紫征(LCS)时,在LCI观察后进行目标活检。对既没有WFE也没有LCS的患者进行随机活检。主要终点是每位患者白光和LCI中GIM诊断的准确性,次要终点是GIM活检和观察者间协议的诊断准确性。
Methods: In prospectively recruited patients, the whole antrum was observed by white light imaging (WLI) followed by LCI. When a whitish flat elevation (WFE) in WLI and a lavender color sign (LCS) in LCI were detected, target biopsies were performed after LCI. Random biopsies were performed in patients who had neither WFE nor LCS. The primary endpoint was the diagnostic accuracy of GIM per patient in WLI and LCI and the secondary endpoints were that of GIM per biopsy and interobserver agreement.
03
结果
分析了128位患者的数据,其中58名患者(45.3%)在胃窦有组织学GIM。白光和LCI检测GIM的患者收益分别为19.0%(11/58)和91.4%(53/58)。GIM目标组织活检的诊断准确性在白光中为23.7%,在LCI中为84.2%。3位医生的Kappa值分别为WFE 0.6、LCS 0.78。
Results: Data from 128 patients were analyzed and 58 patients (45.3%) had histological GIM in the antrum. The per-patient yields of WLI and LCI to detect GIM were 19.0% (11/58) and 91.4% (53/58) respectively. Diagnostic accuracies of target biopsies for GIM were 23.7% in WLI and 84.2% in LCI. Kappa values among 3 doctors were 0.60 for WFE and 0.78 for LCS respectively.
声明
富士胶片内镜世界(LIFE World)所登载的内容及其版权和使用权归作者本人与富士胶片所有。如发现会员擅自复制、更改、公开发表或其他以盈利为目的的使用,富士胶片将追究其法律责任。网站信息中涉及的治疗手技皆为术者个人针对该名患者特定体质及健康状况所采取的手法;术者对器械和药品种类的选择,也受到手术发生时间、地点等诸多因素的影响。因而相关内容及信息仅供会员参考。如盲目使用网站信息中涉及的治疗手技而发生意外,恕富士胶片及本网站对此不承担任何责任。